Scientific Documents and Publications
ESC Working Group on Myocardial and Pericardial Diseases
Publications by your Working Group
Scientific Statements
Our scientific statements interpret scientific evidence and give you our summary position on the topic without offering specific advice
Recommended Reading
Topical articles suggested by the Working Group
Commented Articles
A selection of interesting papers explained and commented on by members of the Working Group
Key Messages Booklets
Diagnosis and management of cardiac manifestations in anderson fabry disease and glycogen storage diseases
The aim of this document is to describe general and cardiac manifestations of AFD and increase the awareness about the disease among cardiologists.
Diagnosis and management of myocardial involvement in systemic immune-mediated disease
The aim of this multidisciplinary document is to help cardiologists and non-cardiac specialists to select the appropriate diagnostic workup in SIDs, setting the stage for future therapeutic choices.
Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implication
The aim of this document is to update the definition of DCM to take into account its diverse aetiology and clinical manifestations in patients and relatives. We do not describe the general management of left ventricular systolic dysfunction as this is covered in existing European Society of Cardiology (ESC) heart failure guidelines but do consider the implications of an aetiology oriented approach to therapy.
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis
In this document, an expert consensus group has reviewed the current literature on clinical presentation, diagnosis, and treatment of myocarditis and propose new diagnostic criteria for clinically suspected myocarditis. The aims are to bridge the gap between clinical and tissue-based diagnosis, to improve management and provide a common reference point for future registries and multicentre randomised controlled trials of aetiology driven treatment in inflammatory heart muscle disease.
ESC Practice Guidelines
2025 ESC Guidelines for the management of myocarditis and pericarditis
These guidelines introduce a comprehensive, patient-oriented framework for the diagnosis and management of IMPS, spanning the full disease spectrum.
2023 ESC Guidelines for the management of endocarditis
The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease Guidelines
Endomyocardial biopsy remains a debated tool in cardiovascular care. The latest guidelines clarify when EMB adds diagnostic, prognostic, and therapeutic value—balancing benefits against procedural risks.